Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
J-STAR Research, Inc., a leading name in the biotechnology sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2010, the company has established itself as a pioneer in advanced research and development, focusing on innovative solutions in drug discovery and development.
J-STAR Research offers a unique portfolio of services, including high-throughput screening, assay development, and custom synthesis, tailored to meet the specific needs of pharmaceutical and biotech clients. Their commitment to cutting-edge technology and scientific excellence has positioned them as a trusted partner in the industry.
With a reputation for delivering high-quality results and a strong emphasis on collaboration, J-STAR Research has achieved notable milestones, including partnerships with leading academic institutions and successful contributions to numerous drug development projects.
-2 vs industry average
J-STAR Research, Inc.’s score of 31 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
No reported emissions data is available for J-STAR Research, Inc. yet.
J-STAR Research, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Porton Pharma Solutions Ltd., which may influence its climate commitments and reporting practices.
As part of its corporate family relationship, J-STAR Research, Inc. inherits climate initiatives and targets from Porton Pharma Solutions Ltd. However, there are no documented reduction targets or climate pledges available for J-STAR Research, Inc. at this time. This lack of specific data suggests that the company may still be in the process of establishing its own emissions reduction strategies or aligning with broader corporate sustainability goals set by its parent organisation.
In summary, while J-STAR Research, Inc. does not currently provide emissions data or specific climate commitments, it is positioned within a corporate structure that may guide its future environmental initiatives through the practices of Porton Pharma Solutions Ltd.
No climate goals have been disclosed for J-STAR Research, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for J-STAR Research, Inc. yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more